CAMTA1-AS2

Across TCGA pan-cancer cohorts, CAMTA1-AS2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CAMTA1-AS2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where CAMTA1-AS2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CAMTA1-AS2 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

BRCA and KIRC are the cancer types where CAMTA1-AS2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CAMTA1-AS2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.038	.011	4	view →
KIRC	All	II,III,IV	−0.032	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CAMTA1-AS2–BRCA

Open the BRCA breakdown →